Deerfield Management Company, L.p. (series C)
Annual return '25
-7.2%
SPY '25
+17.7%
Alpha
-25.0ptsvs SPY
Invested
$8.5B
Holdings
91
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 99%. 3 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$NUVL
NUVALENT INC
Q4 2025: Exited (was 17.99M shares)
20.9%
02
$BKD 3.5 10/15/29
BROOKDALE SR LIVING INC
Held since at least Q1 2024
6.0%
03
$COGT
COGENT BIOSCIENCES INC
Q4 2025: Exited (was 9.05M shares)
4.1%
04
$PRAX
PRAXIS PRECISION MEDICINES I
Q4 2025: Exited (was 840.9k shares)
3.7%
05
$VTRS
VIATRIS INC
Q4 2025: Exited (was 24.10M shares)
3.2%
06
$UTHR
UNITED THERAPEUTICS CORP DEL
Q4 2025: Exited (was 426.0k shares)
3.2%
07
$RVMD
REVOLUTION MEDICINES INC
Q4 2025: Exited (was 3.65M shares)
2.6%
08
$MIRM 4 05/01/29
MIRUM PHARMACEUTICALS INC
Q4 2025: Exited (was 70.00M shares)
2.5%
09
$ARWR 0 01/15/32
ARROWHEAD PHARMACEUTICALS IN
Held since at least Q1 2024
2.4%
10
$CELC
CELCUITY INC
Q4 2025: Exited (was 733.5k shares)
2.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:13 UTC.